Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Mayumi Nakagawa

Concepts (217)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Papillomavirus Infections
15
2024
163
5.000
Why?
Human papillomavirus 16
11
2021
48
3.900
Why?
Uterine Cervical Neoplasms
10
2024
276
3.640
Why?
Papillomavirus Vaccines
7
2021
68
3.570
Why?
Oncogene Proteins, Viral
11
2011
57
2.650
Why?
Papillomaviridae
7
2019
107
2.520
Why?
Repressor Proteins
9
2011
165
2.230
Why?
Epitopes, T-Lymphocyte
7
2018
33
2.060
Why?
Cancer Vaccines
3
2021
103
1.690
Why?
T-Lymphocytes
6
2021
373
1.510
Why?
Candida
4
2018
67
1.450
Why?
CD8-Positive T-Lymphocytes
6
2018
116
1.420
Why?
Cervix Uteri
3
2021
53
0.950
Why?
Uterine Cervical Dysplasia
2
2015
51
0.900
Why?
Immunity, Cellular
4
2013
80
0.790
Why?
Lymphocytes, Tumor-Infiltrating
1
2021
74
0.780
Why?
Langerhans Cells
3
2018
11
0.760
Why?
Epitopes
2
2015
89
0.760
Why?
Viral Load
2
2019
85
0.710
Why?
Neoplasms
2
2021
1316
0.710
Why?
Cell Cycle Checkpoints
1
2019
35
0.690
Why?
Health Education
1
2021
179
0.690
Why?
HLA Antigens
4
2006
55
0.670
Why?
Colorectal Neoplasms
1
2021
236
0.640
Why?
CD4-Positive T-Lymphocytes
3
2018
180
0.610
Why?
Adult
20
2021
14207
0.590
Why?
Humans
40
2024
54284
0.580
Why?
Female
28
2024
28441
0.570
Why?
Health Knowledge, Attitudes, Practice
1
2021
543
0.560
Why?
Plasma Exchange
2
2014
33
0.550
Why?
Cross Protection
1
2015
6
0.530
Why?
T-Lymphocytes, Regulatory
2
2016
85
0.530
Why?
Colposcopy
1
2015
19
0.520
Why?
Interleukin-12
2
2018
37
0.510
Why?
Adjuvants, Immunologic
2
2018
61
0.500
Why?
Immunity, Innate
1
2015
114
0.490
Why?
Lectins, C-Type
1
2013
32
0.480
Why?
Interferon-gamma
2
2012
195
0.480
Why?
Health
1
2013
29
0.470
Why?
Papillomavirus E7 Proteins
8
2018
33
0.470
Why?
Young Adult
9
2021
4318
0.450
Why?
Patient Selection
1
2015
286
0.450
Why?
Middle Aged
14
2021
13088
0.440
Why?
Afibrinogenemia
1
2012
5
0.440
Why?
Enzyme-Linked Immunospot Assay
1
2012
2
0.430
Why?
T-Lymphocytes, Cytotoxic
4
2009
72
0.430
Why?
Breast Neoplasms
1
2021
1248
0.410
Why?
Vaginal Smears
3
2021
31
0.400
Why?
Early Detection of Cancer
3
2021
162
0.390
Why?
Cell Proliferation
5
2021
1096
0.390
Why?
Plateletpheresis
1
2010
8
0.390
Why?
Warts
1
2010
23
0.390
Why?
Antigens, Fungal
1
2010
31
0.380
Why?
Blood Preservation
1
2010
29
0.380
Why?
Dermatitis
1
2010
42
0.380
Why?
Blood Proteins
1
2010
100
0.370
Why?
Anaphylaxis
1
2010
71
0.370
Why?
Cells, Cultured
5
2021
1737
0.340
Why?
Antigens, Viral
2
2009
58
0.330
Why?
Telemedicine
1
2015
449
0.330
Why?
Human papillomavirus 18
1
2008
10
0.330
Why?
Immunotherapy
1
2010
263
0.330
Why?
Blood Platelets
1
2010
269
0.320
Why?
Host-Pathogen Interactions
2
2021
143
0.310
Why?
Vaccinia virus
1
2007
7
0.300
Why?
Dendritic Cells
1
2008
142
0.300
Why?
Immunophenotyping
1
2007
117
0.290
Why?
Immunoenzyme Techniques
1
2007
165
0.290
Why?
Isoantibodies
1
2004
31
0.250
Why?
Neoplasm Grading
2
2021
131
0.250
Why?
Lead
1
2004
32
0.250
Why?
Cell Line, Tumor
5
2021
1550
0.250
Why?
Infant, Very Low Birth Weight
1
2004
47
0.250
Why?
Aged
9
2021
10054
0.240
Why?
Oropharyngeal Neoplasms
1
2024
14
0.240
Why?
Neutropenia
1
2004
120
0.240
Why?
Coinfection
1
2024
34
0.240
Why?
Anus Neoplasms
1
2024
33
0.240
Why?
DNA, Viral
3
2011
142
0.240
Why?
Penile Neoplasms
1
2024
43
0.230
Why?
Blood Transfusion
1
2004
138
0.230
Why?
High-Throughput Nucleotide Sequencing
2
2021
206
0.220
Why?
Adolescent
5
2021
6897
0.220
Why?
Capsid Proteins
1
2002
24
0.220
Why?
Antibody Formation
1
2002
69
0.210
Why?
Genes, T-Cell Receptor
1
2021
5
0.210
Why?
Clone Cells
3
2007
89
0.210
Why?
Clinical Trials, Phase I as Topic
1
2021
30
0.210
Why?
Cytokines
2
2016
676
0.200
Why?
Remission Induction
1
2021
221
0.200
Why?
Treatment Outcome
3
2021
5604
0.200
Why?
Cystadenocarcinoma, Serous
1
2021
74
0.200
Why?
Left-Right Determination Factors
1
2020
1
0.200
Why?
Nodal Protein
1
2020
3
0.200
Why?
Videotape Recording
1
2021
30
0.200
Why?
Pilot Projects
2
2021
808
0.190
Why?
Lymphocyte Activation
1
2021
197
0.190
Why?
Mammography
1
2021
95
0.190
Why?
Mass Screening
2
2021
370
0.190
Why?
Focus Groups
1
2021
208
0.190
Why?
Amino Acid Sequence
3
2008
767
0.190
Why?
Enzyme-Linked Immunosorbent Assay
3
2010
314
0.180
Why?
Metagenome
1
2019
44
0.180
Why?
Feasibility Studies
1
2021
398
0.180
Why?
Parenteral Nutrition
1
2019
24
0.170
Why?
Male
10
2024
27334
0.170
Why?
Glioblastoma
1
2020
99
0.170
Why?
Dose-Response Relationship, Drug
2
2016
1476
0.170
Why?
Up-Regulation
1
2020
508
0.170
Why?
Health Behavior
1
2021
277
0.160
Why?
Transplantation Conditioning
1
2019
86
0.160
Why?
DNA
1
2021
581
0.160
Why?
HLA-B Antigens
2
2008
7
0.150
Why?
Leukocytes, Mononuclear
2
2016
133
0.150
Why?
Multiple Myeloma
1
2012
3035
0.150
Why?
Bacteria
1
2019
258
0.150
Why?
Time Factors
2
2021
3213
0.150
Why?
Age Factors
1
2021
1198
0.150
Why?
Brain Neoplasms
1
2020
284
0.150
Why?
Cell Line
2
2012
1153
0.150
Why?
Ovarian Neoplasms
1
2021
472
0.150
Why?
Histocompatibility Antigens Class II
2
2008
43
0.140
Why?
Vaccines, Subunit
1
2016
20
0.140
Why?
Head and Neck Neoplasms
1
2019
335
0.140
Why?
Body Mass Index
1
2019
713
0.130
Why?
Adaptive Immunity
1
2015
39
0.130
Why?
Chromatography, Liquid
1
2016
243
0.130
Why?
Molecular Sequence Data
2
2008
980
0.130
Why?
Leukocyte Count
2
2004
77
0.130
Why?
Tandem Mass Spectrometry
1
2016
248
0.130
Why?
Factor VIII
1
2014
28
0.120
Why?
ADAM Proteins
1
2014
24
0.120
Why?
Purpura, Thrombotic Thrombocytopenic
1
2014
17
0.120
Why?
Peptides
2
2006
276
0.120
Why?
Proteome
1
2016
178
0.120
Why?
Antigens, CD1
1
2013
8
0.120
Why?
Mannose-Binding Lectins
1
2013
10
0.120
Why?
Receptors, Pattern Recognition
1
2013
5
0.120
Why?
Indicators and Reagents
1
2013
42
0.120
Why?
Intracellular Space
1
2013
31
0.120
Why?
Skin Tests
1
2013
58
0.120
Why?
Vaccination
1
2016
294
0.120
Why?
Hematopoietic Stem Cell Transplantation
1
2019
573
0.120
Why?
Cadherins
1
2013
72
0.120
Why?
Proteomics
1
2016
343
0.110
Why?
Rural Health Services
1
2015
175
0.110
Why?
Communication
1
2015
273
0.110
Why?
Research Design
1
2015
374
0.110
Why?
Antigens, CD
1
2013
242
0.110
Why?
Socioeconomic Factors
1
2015
642
0.110
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2013
673
0.110
Why?
Longitudinal Studies
2
2005
746
0.100
Why?
Injections, Intralesional
1
2010
38
0.100
Why?
Isotonic Solutions
1
2010
21
0.100
Why?
P-Selectin
1
2010
33
0.100
Why?
Platelet Transfusion
1
2010
32
0.100
Why?
Platelet Aggregation
1
2010
82
0.090
Why?
Platelet Activation
1
2010
50
0.090
Why?
Sodium Chloride
1
2010
67
0.090
Why?
Hypersensitivity
1
2010
82
0.090
Why?
Retrospective Studies
3
2019
6432
0.090
Why?
HLA-A Antigens
1
2008
13
0.080
Why?
Antigen Presentation
1
2008
28
0.080
Why?
Polymerase Chain Reaction
1
2010
531
0.080
Why?
Immunologic Memory
1
2008
32
0.080
Why?
Histocompatibility Antigens Class I
1
2008
52
0.080
Why?
Signal Transduction
2
2020
1753
0.080
Why?
DNA, Recombinant
1
2007
17
0.080
Why?
Genes, MHC Class I
1
2006
13
0.070
Why?
Binding, Competitive
1
2006
113
0.070
Why?
Arkansas
1
2013
2100
0.070
Why?
Animals
2
2019
14385
0.070
Why?
Neoplasm Staging
1
2008
806
0.070
Why?
Calgranulin B
1
2005
6
0.070
Why?
Calgranulin A
1
2005
7
0.070
Why?
Immunomagnetic Separation
1
2004
9
0.060
Why?
Epitope Mapping
1
2004
12
0.060
Why?
Risk Factors
1
2013
3935
0.060
Why?
Phosphorylation
2
2020
614
0.060
Why?
Sensitivity and Specificity
1
2005
923
0.060
Why?
Tumor Virus Infections
1
2002
43
0.050
Why?
Antibodies, Viral
1
2002
124
0.050
Why?
Lactobacillus
1
2021
6
0.050
Why?
SOX Transcription Factors
1
2021
4
0.050
Why?
Immunoglobulin G
1
2002
226
0.050
Why?
Neuroendocrine Cells
1
2021
11
0.050
Why?
Biological Specimen Banks
1
2021
21
0.050
Why?
Cytodiagnosis
1
2021
44
0.050
Why?
Cytoplasm
1
2021
108
0.050
Why?
Cobalt
1
2020
19
0.050
Why?
Vulnerable Populations
1
2020
44
0.050
Why?
Epithelial-Mesenchymal Transition
1
2020
53
0.050
Why?
Cell Hypoxia
1
2020
87
0.050
Why?
Recurrence
1
2002
690
0.050
Why?
Neoplastic Stem Cells
1
2021
103
0.050
Why?
Community Health Workers
1
2020
48
0.050
Why?
Cell Movement
1
2021
271
0.050
Why?
Cohort Studies
1
2004
1543
0.050
Why?
Multivariate Analysis
1
2021
643
0.040
Why?
Parenteral Nutrition, Total
1
2019
26
0.040
Why?
Sequence Analysis, DNA
1
2019
273
0.040
Why?
Cell Survival
1
2020
657
0.040
Why?
Cell Differentiation
1
2021
720
0.040
Why?
Phenotype
1
2021
820
0.040
Why?
Linear Models
1
2019
309
0.040
Why?
Immunity, Humoral
1
2018
25
0.040
Why?
Models, Biological
1
2021
823
0.040
Why?
Infant, Newborn
1
2004
2907
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2020
866
0.030
Why?
Prognosis
1
2021
2118
0.030
Why?
Autoantibodies
1
2014
132
0.030
Why?
Immunosuppressive Agents
1
2014
248
0.030
Why?
Mice, Inbred C57BL
1
2018
1999
0.030
Why?
Combined Modality Therapy
1
2014
692
0.030
Why?
Mice
1
2018
6413
0.020
Why?
Casein Kinase II
1
2005
11
0.020
Why?
Cell Division
1
2005
330
0.010
Why?
Nakagawa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description